Biocompatible PAMAM‐PLGA‐PCL Nanocarrier for Efficient Curcumin Delivery to Lung Cancer Cells: In Vitro Studies
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202401106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Yasir Qasim Almajidi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy (pharmaceutics), Baghdad College of Medical Sciences, 10047, Baghdad, Iraq. Hauptthemen laut MEDLINE: Curcumin, Dendrimers, Polyesters, Drug Carriers. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Abstract (Originalsprache)
Lung cancer, as the leading cause of death among other types of cancer, has a high rate of incidence throughout the world. Although conventional modalities, like chemotherapy, have been applied for the inhibition of this cancer, they have not led to the suppression of lung cancer owing to their deficiencies. Thus, we developed a novel polylactic‐co‐glycolic acid (PLGA)‐polyamidoamine G4 (PAMAM G4)‐polycaprolactone (PCL) nanocarrier for efficient delivery of curcumin (Cur) to A549 lung cancer cells. The synthesized nanocarrier was characterized by applying analytical techniques, FT‐IR, DLS, TEM, and TGA. Successful synthesis, nano‐size diameter (40–80 nm), near neutral surface charge (8.0 mV), and high drug entrapment (11.5 %) were measured for the nanocarrier. Controlled (about 5 folds within first 2 h) and pH‐sensitive (2–3 folds faster within first hours) Cur release observed for PLGA‐PAMAM‐PCL‐Cur. Cell viability test (MTT assay) indicated the high capability of nanocarrier in suppression of A549 cancer cells (21 % viability after 24 h of treatment with 200 nM) while did not result in toxicity on MSC normal cells. The IC 50 observed for 50 nM at 24 h of post‐treatment in A549 cells. The qRT‐PCR technique indicated inducing the expression of apoptotic genes (Caspase9 and Bax) by 6–8 folds and suppressing anti‐apoptotic gene (Bcl2) by 7 folds. ROS considerably increased in cancer cells as well. This nanocarrier would be a promising drug delivery system against lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy (pharmaceutics), Baghdad College of Medical Sciences, 10047, Baghdad, Iraq.
- Department of Pharmaceutics, College of Pharmacy, Al-Nahrain university, 10072, Baghdad, Iraq.
ORCID-Profile: Yasir Qasim Almajidi, Ali Q Jawad, Ahmed Abdulameer Albadri
Zitieren
APA
Qasim Almajidi, Y., Jawad, A. Q., & Abdulameer Albadri, A. (2024). Biocompatible PAMAM‐PLGA‐PCL Nanocarrier for Efficient Curcumin Delivery to Lung Cancer Cells: In Vitro Studies. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401106
Vancouver
Qasim Almajidi Y, Jawad AQ, Abdulameer Albadri A. Biocompatible PAMAM‐PLGA‐PCL Nanocarrier for Efficient Curcumin Delivery to Lung Cancer Cells: In Vitro Studies. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202401106
BibTeX
@article{QasimAlmajidi2024,
author = {Qasim Almajidi, Yasir and Jawad, Ali Q and Abdulameer Albadri, Ahmed},
title = {Biocompatible PAMAM‐PLGA‐PCL Nanocarrier for Efficient Curcumin Delivery to Lung Cancer Cells: In Vitro Studies},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202401106}
}
EUVIMED